The National Agency of Drug and Food Control in Indonesia announced the expansion of the measles vaccine to include at-risk adults, aiming to control an expected outbreak in 2026. This decision responds to a rise in measles cases in several regions.
The Indonesian Drug and Food Control Agency announced the availability of the Bio Farma measles vaccine for adults, starting April 7, 2026. This initiative aims to provide an affordable option to combat the risk of infection, particularly among healthcare workers.
The Indonesian Food and Drug Authority has announced the expansion of the measles vaccine to include adults, aiming to protect health workers from the disease. This decision comes amid a rise in measles cases in the country.
The Indonesian Ministry of Health has announced the start of a vaccination campaign against measles for health workers after receiving confirmation from the drug monitoring agency regarding the vaccine's effectiveness for adults. The campaign targets the most affected areas.